Skip to content

Clinical trials

Terminated Observational trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Observational Status: Terminated Country / region: China Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20091
20101
20114
20123
20133
20144
20154
20164
20176
201810
20192
20202
20212
20229
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Pfizer3
Children's Hospital of Fudan University2
Chinese University of Hong Kong2
Johnson & Johnson Medical, China2
National Cancer Institute (NCI)2
Shanghai Jiao Tong University School of Medicine2
Takeda2
West China Hospital2
113th Hospital of Chinese People's Liberation Army1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms3
Diabetes Mellitus, Type 23
Lung Neoplasms3
Esophageal Neoplasms2
Liver Neoplasms2
Multiple Myeloma2
Spondylitis, Ankylosing2
Achondroplasia1
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.